That's not really an analysis, just the statement of facts: AVH P/S ratio is 83 while the normal (typical) company (including pharma) P/S is between 1-3. Therefore the AVH sales have to grow 42- to 83-fold to match the share price.
Broker analysis, page-56
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.02 |
Change
-0.080(2.58%) |
Mkt cap ! $212.9M | |||
| Open | High | Low | Value | Volume |
| $3.09 | $3.11 | $3.00 | $438.3K | 144.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3373 | $3.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.04 | 69 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |